Literature DB >> 11350832

Identification of residues critical for enzymatic activity in the domain encoded by exons 8 and 9 of the human inducible nitric oxide synthase.

N T Eissa1, C M Haggerty, C D Palmer, W Patton, J Moss.   

Abstract

Overproduction of nitric oxide (NO) by inducible NO synthase (iNOS) has been implicated in the pathogenesis of several diseases including airway inflammation of asthma. iNOS is active only as a homodimer. We previously demonstrated that the region encoded by exons 8 and 9 is critical for dimerization. In this study, alanine-scanning mutagenesis was used to identify critical amino acids in that region by expression of mutant proteins in human embryonic kidney 293 cells. All iNOS mutants yielded iNOS protein as detected by Western analysis. Four iNOS mutants with alanine replacing Trp260, Asn261, Tyr267, or Asp280 did not generate NO. Dimer formation was tested by sodium dodecyl sulfate polyacrylamide gel electrophoresis at 4 degrees C, followed by immunoblotting. Wild-type iNOS migrated both as monomers and dimers. iNOS mutants with alanine replacing Trp260, Asn261, or Tyr267, however, migrated only as monomers, suggesting that their inability to produce NO is related to a defect in dimer formation. Interestingly, the Asp280 mutant retained the ability to dimerize, indicating that it represents an inactive form of an iNOS dimer. These data identify four amino acids in exons 8 and 9 critical for iNOS activity, three of which also influence dimerization. These residues are strictly conserved among all NOS isforms and across species. Thus all NOS isoforms share general structural similarities, including specific amino acids critical for dimerization and catalytic activity. These data increase our understanding of the structural elements critical for NO synthesis and lay the groundwork for future studies aimed at downregulation of iNOS activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350832     DOI: 10.1165/ajrcmb.24.5.4324

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  7 in total

1.  Intracellular formation of "undisruptable" dimers of inducible nitric oxide synthase.

Authors:  Pawel J Kolodziejski; Mohammad B Rashid; N Tony Eissa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

2.  Regulation of inducible nitric oxide synthase by aggresome formation.

Authors:  Katarzyna E Kolodziejska; Alan R Burns; Robert H Moore; David L Stenoien; N Tony Eissa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

3.  Characterization of key residues in the subdomain encoded by exons 8 and 9 of human inducible nitric oxide synthase: a critical role for Asp-280 in substrate binding and subunit interactions.

Authors:  D K Ghosh; M B Rashid; B Crane; V Taskar; M Mast; M A Misukonis; J B Weinberg; N T Eissa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

4.  Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors.

Authors:  Pawel J Kolodziejski; Ja-Seok Koo; N Tony Eissa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

5.  Ubiquitination of inducible nitric oxide synthase is required for its degradation.

Authors:  Pawel J Kolodziejski; Aleksandra Musial; Ja-Seok Koo; N Tony Eissa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

6.  Roles of apolipoprotein E (ApoE) and inducible nitric oxide synthase (iNOS) in inflammation and apoptosis in preeclampsia pathogenesis and progression.

Authors:  Luyi Mao; Qiongjie Zhou; Shufeng Zhou; Rhonda R Wilbur; Xiaotian Li
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

7.  Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma.

Authors:  Hicham H Baydoun; Mathew A Cherian; Patrick Green; Lee Ratner
Journal:  Retrovirology       Date:  2015-08-12       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.